Vaishali Pharma Balance Sheet
- Market cap
- ₹106 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹5.86 – ₹10.99
As of FY25, Vaishali Pharma had total assets of ₹69.03 crore and borrowings of ₹12.74 crore, against shareholders' equity of ₹168 crore — a debt-to-equity ratio of 0.35.
Vaishali Pharma balance sheet
As at each financial year end, newest first. H1 = half-year.
| Item | FY25 |
|---|---|
| Equity capital | 120 |
| Reserves | 47.79 |
| Borrowings | 12.74 |
| Other liabilities | 8.5 |
| Total liabilities | 69.03 |
| Fixed assets | 37.17 |
| Capital work in progress | 45 |
| Investments | 15.93 |
| Other assets | 15.93 |
| Total assets | 69.03 |
Balance sheet ratios
- Debt to equity
- 0.35
- Book value per share
- ₹2.86
Source: Company filings (consolidated), in ₹ crore. Data as of 9 October 2026. How this data is compiled.
Vaishali Pharma balance sheet — frequently asked questions
What is the total debt of Vaishali Pharma?
Vaishali Pharma reported borrowings of ₹12.74 crore as of FY25.
What is Vaishali Pharma's debt-to-equity ratio?
Based on the FY25 balance sheet, Vaishali Pharma's debt-to-equity ratio is 0.35 — borrowings of ₹12.74 crore against equity capital and reserves of ₹168 crore.
What are Vaishali Pharma's total assets?
Vaishali Pharma's total assets were ₹69.03 crore as of FY25, including fixed assets of ₹37.17 crore and investments of ₹15.93 crore.
What is the book value per share of Vaishali Pharma?
The book value per share of Vaishali Pharma is ₹2.86, based on the latest reported balance sheet.
Same Data For Peers
Trade Vaishali Pharma With ATS
Track VAISHALI live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.